Ask the Right Questions of A.I.

Prometheus Biosciences Reports Exceptional Results in Phase 2 Studies

April 20, 2003

Prometheus Biosciences Reports Exceptional Results in Phase 2 Studies

April 20, 2023 | Atomo A.I. Insights

“The data were truly exceptional.” In a recent presentation at the Oppenheimer 33rd Annual Healthcare Conference, Prometheus Biosciences Reports Exceptional Results in Phase 2 Studies, Advancing to Phase 3 for Ulcerative Colitis and Crohn’s Disease.

Related Posts

A.I. Tools are developed to help us do our jobs better

A.I. Tools are developed to help us do our jobs better

Ask the Right Questions of A.I. A.I. Tools are developed to help us do our jobs better July 5, 2023A.I. Tools are developed to help us do our jobs better July 5, 2023 | Ask the Right Questions of A.I. In a recent Wall Street Journal opinion letter, Anthony Mercando,...

read more
Exciting news in the field of precision medicine!

Exciting news in the field of precision medicine!

Ask the Right Questions of A.I. Exciting news in the field of precision medicine! June 8, 2023Exciting news in the field of precision medicine! June 8, 2023 | Ask the Right Questions of A.I. The recent May 2023 Journal of Clinical Oncology published how systems...

read more

Ready to see what Atomo can do for you?

Let us introduce you to Atomo’s proven abilities and technologies that are empowering the future of healthcare.

Reimagine Better Solutions

Atomo can help you leverage technology and big data to solve your most difficult healthcare challenges

108 Wild Basin Rd. Suite 250, Austin, TX, USA 78746

(512) 680-2383

info@atomohealth.com